The $12 price target sits squarely within the range of Wall Street analyst forecasts. According to MarketWatch, four analysts covering UAMY have an average 12-month price target of $12.56, with individual estimates ranging from $11.75 to $13.50. H.C. Wainwright, one of the most active firms on the name, raised its target to $11.75 in May 2026, while Alliance Global Partners maintains a Street-high target of $14.00. At $12.00, the stock would roughly double from its August 2026 trading range, crossing a psychologically important round-number threshold that often attracts additional attention from momentum-oriented traders.
United States Antimony Corporation, founded in 1968 and headquartered in Dallas, Texas, is a fully integrated mining, milling, smelting, and selling company. It produces antimony, zeolite, and precious metals, and operates the only significant antimony smelter in the United States. Antimony is classified as a critical mineral by the U.S. government because of its essential role in defense applications — including ammunition primers, flame retardants, and night-vision equipment — as well as in solar glass manufacturing. The company also produces zeolite products used in water filtration, soil amendment, and nuclear waste remediation.
As of the most recent trading session, UAMY shares closed at $6.67, giving the company a market capitalization of approximately $1.02 billion. The stock has experienced dramatic volatility: the 52-week range spans from $3.41 to $19.71, and the all-time closing high of $17.47 was reached in October 2025. The stock currently trades below both its 50-day moving average of $6.84 and its 200-day moving average of $8.00, indicating near-term technical weakness despite its strong multi-year return of over 1,400% across the past three years.
The single most important catalyst is the company's $245 million sole-source contract with the Defense Logistics Agency. During the first quarter of 2026, UAMY recognized no revenue under this contract, which management and analysts characterized as a transitional buildout quarter. The company reported a 76% quarter-over-quarter increase in antimony inventory, suggesting that production is ramping ahead of future DLA deliveries. H.C. Wainwright analysts noted that "meaningful capital" is being deployed into inventory, mining capacity, and workforce expansion ahead of the contract ramp.
Beyond the DLA contract, the joint venture with Americas Gold and Silver to build a hydrometallurgical facility at the Galena Complex in Idaho's Silver Valley represents another significant growth vector. The facility is designed to improve metal recoveries and reduce processing costs for copper, silver, and antimony. A sixfold capacity expansion at the Thompson Falls smelter in Montana, targeted for completion by year-end, could further boost production volumes. The company is also advancing its Fostung tungsten resource and a planned hydrometallurgical facility in Bolivia.
On the geopolitical front, China controls over 60% of global antimony production. Export restrictions imposed by Beijing have tightened global supply and elevated antimony prices, directly benefiting UAMY as the primary domestic alternative. Any further deterioration in U.S.-China trade relations around critical minerals could reinforce the scarcity premium embedded in UAMY's valuation.
Execution risk is the central obstacle. The Galena facility, Thompson Falls expansion, Fostung tungsten resource, and Bolivian hydromet project all require timely development, permitting, and funding. Any single delay could disrupt the revenue trajectory that analysts have modeled. Permitting setbacks in Alaska and Ontario, environmental opposition, and supply chain disruptions affecting ore quality represent additional operational hazards.
Financial performance has been inconsistent. In Q1 2026, UAMY reported revenue of just $6.8 million — well below the $19.7 million analyst estimate — and a net loss of $11.3 million, or $0.08 per share. The company holds $12.8 million in government grant receivables, which partially strengthens the balance sheet, but free cash flow turned deeply negative in late 2025. A forward P/E ratio ranging from 36 to 72 depending on the data source reflects aggressive growth expectations rather than current profitability.
Geopolitical risk cuts both ways. A potential U.S.-China trade agreement that results in Beijing lifting antimony export restrictions could release a wave of cheaper Chinese supply into global markets, compressing antimony prices and eroding UAMY's scarcity premium. Short interest remains elevated at approximately 21.76% of the float, meaning a sizable portion of market participants are positioned for downside.
Wall Street sentiment is broadly constructive with a consensus rating of "Moderate Buy" to "Strong Buy" depending on the data provider. The six-analyst consensus tracked by MarketBeat carries an average price target of $9.25, while the four-analyst consensus followed by MarketWatch and StockAnalysis sits at a higher $12.56 average. The upward trajectory of price targets over the past year is notable: H.C. Wainwright has raised its target from $2.60 in May 2025 to $11.75 in May 2026, reflecting growing confidence in the operational story. However, Weiss Ratings initiated coverage in March 2026 with a Sell rating, providing a counterpoint to the otherwise bullish consensus.
From a technical perspective, the $10 level represents a significant resistance zone — a round-number psychological barrier that sits just above the 200-day moving average. A sustained move above $10 would likely require confirmation from both improving fundamentals and broader market acceptance of the growth narrative. The $8.00 area, roughly aligned with the 200-day moving average, serves as the first major hurdle that must be cleared before $10 and ultimately $12 come into focus. On the downside, the $5.00 area has acted as a support zone, with one analyst maintaining a $5.00 price target as the bear-case scenario.
Navigating a volatile stock like United States Antimony requires timely and data-driven decision-making. Tickeron's AI Daily Buy/Sell Signals uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI-driven analysis. Traders can leverage these signals to identify emerging opportunities, monitor existing positions, and stay ahead of changing market trends more efficiently. For those tracking UAMY and similar critical-mineral plays, AI-driven signal monitoring can help cut through the noise of daily price swings.
The question of whether United States Antimony can reach $12 per share is not about whether the stock has been there before — it briefly traded above that level during its 2025 rally toward $19.71 — but rather whether current fundamentals and catalysts can support a sustained move back to that level from the mid-$6 range. The bullish case rests on the $245 million DLA contract ramping into meaningful revenue, new processing capacity coming online, and geopolitical dynamics continuing to favor domestic critical-mineral producers. The bearish case points to execution risk across a complex project pipeline, persistent quarterly losses, and the possibility that much of the good news is already priced in at a P/S ratio above 22x. Investors should monitor DLA contract revenue recognition in upcoming quarterly reports, progress updates on the Galena joint venture, and any shifts in U.S.-China critical-mineral trade policy. The $12 target is achievable but demands near-flawless execution and a favorable macro backdrop.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, UAMY has been closely correlated with MP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if UAMY jumps, then MP could also see price increases.
| Ticker / NAME | Correlation To UAMY | 1D Price Change % | ||
|---|---|---|---|---|
| UAMY | 100% | +7.44% | ||
| MP - UAMY | 67% Closely correlated | +2.86% | ||
| NB - UAMY | 64% Loosely correlated | -1.92% | ||
| CRML - UAMY | 64% Loosely correlated | -0.45% | ||
| USAR - UAMY | 62% Loosely correlated | +1.09% | ||
| TMC - UAMY | 57% Loosely correlated | -1.34% | ||
More | ||||
| Ticker / NAME | Correlation To UAMY | 1D Price Change % |
|---|---|---|
| UAMY | 100% | +7.44% |
| UAMY (2 stocks) | 76% Closely correlated | +4.64% |
| Non Energy Minerals (150 stocks) | 12% Poorly correlated | +1.39% |